Clearbridge Health

Clearbridge Health Financing Cash Flow

The Net Financing Cash Flow of Clearbridge Health (1H3.SI) as of Nov 14, 2026 is -2.56 M SGD. In the previous year, Net Financing Cash Flow was 2.46 M SGD — a change of -203.77% (lower).

Financing Cash Flow

-2.56 MSGD

YoY

-203.77%

Last updated:

Net Financing Cash Flow of Clearbridge Health is 2022 -2.56 M SGD. Net Financing Cash Flow of Clearbridge Health was 2021 2.46 M SGD. It decreases by -203.77% lower compared to the previous year.

The Clearbridge Health Financing Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financing Cash Flow
Date
Financing Cash Flow
Jan 1, 2015
7.50 M SGD
Jan 1, 2016
10.59 M SGD
Jan 1, 2017
22.09 M SGD
Jan 1, 2018
708,000.00 SGD
Jan 1, 2019
26.26 M SGD
Jan 1, 2020
-1.03 M SGD
Jan 1, 2021
2.46 M SGD
Jan 1, 2022
-2.56 M SGD
The Clearbridge Health Financing Cash Flow history
YEARFinancing Cash FlowYoY
-2.56 MSGD-203.77%
2.46 MSGD-340.39%
-1.03 MSGD-103.90%
26.26 MSGD+3,609.46%
708,000.00SGD-96.79%
22.09 MSGD+108.58%
10.59 MSGD+41.26%
7.50 MSGD+190.77%
2.58 MSGD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Clearbridge Health Stock analysis

What does Clearbridge Health do? Clearbridge Health Ltd is an international company in the healthcare and diagnostics sector based in Singapore. The company was founded in 2017 and focuses on the use of innovative technology, information, and communication systems to provide efficient and precise diagnostics and medical care. The business model of Clearbridge Health is based on a wide range of services and products, divided into three segments: Clinical diagnostics, healthcare services, and digitization. These divisions are interconnected and allow the company to offer a comprehensive range of healthcare services. In the field of clinical diagnostics, the company offers a variety of laboratory and radiology services. Clearbridge Health has a strong presence in Singapore and Indonesia, where it has several diagnostic laboratories specializing in areas such as pathology, microbiology, genetics, and molecular diagnostics. In addition, the company has partnerships with leading diagnostic laboratories worldwide to provide its customers with an even broader range of diagnostic options. In the healthcare services segment, Clearbridge Health offers a wide range of services including diagnosis, treatment, and disease prevention, as well as health management. A key focus in this area is the care of cancer patients. Here, the company has developed a unique self-financing model where it invests in diagnosis and treatment and benefits from the outcomes achieved. The goal is to provide cancer patients with fast diagnosis and comprehensive, personalized treatment. Clearbridge Health has partnerships with leading cancer centers worldwide and utilizes the latest technologies to enable fast and accurate diagnosis. In the digitization segment, Clearbridge Health offers innovative technology solutions to digitalize the healthcare sector and improve efficiency in healthcare delivery. One of the products includes a cloud-based platform for medical imaging called teleradiology. The platform allows for the digital transmission of images from one location to another, saving time and costs and improving efficiency in patient diagnosis and treatment. Clearbridge Health has experienced rapid growth in recent years. The company has expanded its presence in Asia and other parts of the world and continues to pursue an ambitious expansion strategy. The goal is to become a global leader in healthcare and diagnostics. In summary, Clearbridge Health is an innovative company in the healthcare and diagnostics sector that offers a wide range of services and products. The company has a strong presence in Asia and collaborates closely with leading diagnostic laboratories and cancer centers worldwide. Clearbridge Health is committed to improving healthcare delivery and promoting the adoption of innovative technology solutions to enhance efficiency. The company has experienced impressive growth in recent years and continues to pursue an ambitious expansion strategy. Clearbridge Health is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Clearbridge Health stock

Net Financing Cash Flow of Clearbridge Health is -2.56 M SGD in 2022.

Net Financing Cash Flow of Clearbridge Health changed from 2.46 M SGD to -2.56 M SGD, representing a -203.77% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Financing Cash Flow Clearbridge Health since 2006 – with annual values, charts, and detailed analysis.

Financing cash flow measures cash flows from debt issuance/repayment, equity transactions, and dividend payments.

Net Financing Cash Flow's SGD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Net Financing Cash Flow's Clearbridge Health historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Clearbridge Health

All Key Metrics — Clearbridge Health